Medifast Inc (N:MED)

Business Focus: Special Foods & Welbeing Products

Sector:  Consumer Non-Cyclicals Industry:  Food Processing
 
See Regulatory Filings on SEC
Company Contact
Address: 11445 Cronhill Dr
OWINGS MILLS MD 21117-2270
Tel: N/A
Website: https://medifastinc.com
IR: See website
<
Key People
Daniel R. Chard
Chairman of the Board, Chief Executive Officer
James P. Maloney
Chief Financial Officer
Jason L. Groves
Executive Vice President, General Counsel, Corporate Secretary
Claudia C. Greninger
Executive Vice President - Human Resources
Jonathan B Mackenzie
Chief Accounting Officer, Vice President - Finance
Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Steven Zenker
Vice President of Investor Relations
Nicholas M. Johnson
Chief Field Operations
 
Business Overview
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
Financial Overview
For the fiscal year ended 31 December 2023, Medifast Inc revenues decreased 33% to $1.07B. Net income decreased 31% to $99.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Research & Development Expense increase of 2% to $4.6M (expense), Other (expense) income increase from $46K to $95K (expense).
Employees: 634 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $203.41M as of Dec 31, 2023
Annual revenue (TTM): $1,072M as of Dec 31, 2023
EBITDA (TTM): $139.51M as of Dec 31, 2023
Net annual income (TTM): $99.41M as of Dec 31, 2023
Free cash flow (TTM): $68.16M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 10,895,595 as of Feb 6, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.